"Global Opioid Drugs Market Overview:
Global Opioid Drugs Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Opioid Drugs Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Opioid Drugs involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Opioid Drugs Market:
The Opioid Drugs Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Opioid Drugs Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Opioid Drugs Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Opioid Drugs market has been segmented into:
Codeine
Fentanyl
Morphine
Hydrocodone
Oxycodone
and Others
By Application, Opioid Drugs market has been segmented into:
Analgesia
Cough Suppression
and Diarrhea Suppression
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Opioid Drugs market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Opioid Drugs market.
Top Key Players Covered in Opioid Drugs market are:
Teva Pharmaceutical Industries Ltd.
Johnson & Johnson
Endo International plc
Lupin Limited
Cadila Healthcare Limited
Purdue Pharma L.P.
AbbVie Inc.
Fresenius Kabi
Mallinckrodt Pharmaceuticals
Pfizer Inc.
Rhodes Pharmaceuticals L.P.
Sun Pharmaceutical Industries Limited
Nesher Pharmaceuticals (USA) LLC
Amneal Pharmaceuticals LLC
Trevena Inc.
Aurobindo Pharma Limited.
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Opioid Drugs Market by Type
4.1 Opioid Drugs Market Snapshot and Growth Engine
4.2 Opioid Drugs Market Overview
4.3 Codeine
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Codeine: Geographic Segmentation Analysis
4.4 Fentanyl
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Fentanyl: Geographic Segmentation Analysis
4.5 Morphine
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Morphine: Geographic Segmentation Analysis
4.6 Hydrocodone
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Hydrocodone: Geographic Segmentation Analysis
4.7 Oxycodone
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Oxycodone: Geographic Segmentation Analysis
4.8 and Others
4.8.1 Introduction and Market Overview
4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.8.3 Key Market Trends, Growth Factors and Opportunities
4.8.4 and Others: Geographic Segmentation Analysis
Chapter 5: Opioid Drugs Market by Application
5.1 Opioid Drugs Market Snapshot and Growth Engine
5.2 Opioid Drugs Market Overview
5.3 Analgesia
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Analgesia: Geographic Segmentation Analysis
5.4 Cough Suppression
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Cough Suppression: Geographic Segmentation Analysis
5.5 and Diarrhea Suppression
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 and Diarrhea Suppression: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Opioid Drugs Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 TEVA PHARMACEUTICAL INDUSTRIES LTD.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 JOHNSON & JOHNSON
6.4 ENDO INTERNATIONAL PLC
6.5 LUPIN LIMITED
6.6 CADILA HEALTHCARE LIMITED
6.7 PURDUE PHARMA L.P.
6.8 ABBVIE INC.
6.9 FRESENIUS KABI
6.10 MALLINCKRODT PHARMACEUTICALS
6.11 PFIZER INC.
6.12 RHODES PHARMACEUTICALS L.P.
6.13 SUN PHARMACEUTICAL INDUSTRIES LIMITED
6.14 NESHER PHARMACEUTICALS (USA) LLC
6.15 AMNEAL PHARMACEUTICALS LLC
6.16 TREVENA INC.
6.17 AND AUROBINDO PHARMA LIMITED.
Chapter 7: Global Opioid Drugs Market By Region
7.1 Overview
7.2. North America Opioid Drugs Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Codeine
7.2.4.2 Fentanyl
7.2.4.3 Morphine
7.2.4.4 Hydrocodone
7.2.4.5 Oxycodone
7.2.4.6 and Others
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Analgesia
7.2.5.2 Cough Suppression
7.2.5.3 and Diarrhea Suppression
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Opioid Drugs Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Codeine
7.3.4.2 Fentanyl
7.3.4.3 Morphine
7.3.4.4 Hydrocodone
7.3.4.5 Oxycodone
7.3.4.6 and Others
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Analgesia
7.3.5.2 Cough Suppression
7.3.5.3 and Diarrhea Suppression
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Opioid Drugs Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Codeine
7.4.4.2 Fentanyl
7.4.4.3 Morphine
7.4.4.4 Hydrocodone
7.4.4.5 Oxycodone
7.4.4.6 and Others
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Analgesia
7.4.5.2 Cough Suppression
7.4.5.3 and Diarrhea Suppression
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Opioid Drugs Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Codeine
7.5.4.2 Fentanyl
7.5.4.3 Morphine
7.5.4.4 Hydrocodone
7.5.4.5 Oxycodone
7.5.4.6 and Others
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Analgesia
7.5.5.2 Cough Suppression
7.5.5.3 and Diarrhea Suppression
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Opioid Drugs Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Codeine
7.6.4.2 Fentanyl
7.6.4.3 Morphine
7.6.4.4 Hydrocodone
7.6.4.5 Oxycodone
7.6.4.6 and Others
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Analgesia
7.6.5.2 Cough Suppression
7.6.5.3 and Diarrhea Suppression
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Opioid Drugs Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Codeine
7.7.4.2 Fentanyl
7.7.4.3 Morphine
7.7.4.4 Hydrocodone
7.7.4.5 Oxycodone
7.7.4.6 and Others
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Analgesia
7.7.5.2 Cough Suppression
7.7.5.3 and Diarrhea Suppression
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Opioid Drugs Scope:
|
Report Data
|
Opioid Drugs Market
|
|
Opioid Drugs Market Size in 2025
|
USD XX million
|
|
Opioid Drugs CAGR 2025 - 2032
|
XX%
|
|
Opioid Drugs Base Year
|
2024
|
|
Opioid Drugs Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Endo International plc, Lupin Limited, Cadila Healthcare Limited, Purdue Pharma L.P., AbbVie Inc., Fresenius Kabi, Mallinckrodt Pharmaceuticals, Pfizer Inc., Rhodes Pharmaceuticals L.P., Sun Pharmaceutical Industries Limited, Nesher Pharmaceuticals (USA) LLC, Amneal Pharmaceuticals LLC, Trevena Inc., and Aurobindo Pharma Limited..
|
|
Key Segments
|
By Type
Codeine
Fentanyl
Morphine
Hydrocodone
Oxycodone
and Others
By Applications
Analgesia
Cough Suppression
and Diarrhea Suppression
|
